Parkinson's News Today Home | Parkinson's News Today
Top 10 Parkinson’s stories of 2024. In 2024, Parkinson’s News Today kept readers informed with updates on the latest research, treatments, and clinical trials for Parkinson’s disease. Here are the 10 most-read stories in 2024, each with a short summary.
What's New in Parkinson's - Davis Phinney Foundation
6 days ago · December News. A meta-analysis found that tai-chi, yoga, and weight-training can help with dynamic balance for people with Parkinson’s.; Tavapon, a new drug being developed by Abbvie showed signs of improving mobility for people with early-stage Parkinson’s.; A small study reports that sub-optimal settings of DBS systems can impact sleep metrics related to sleep spindle density.
Parkinson's News -- ScienceDaily
5 days ago · Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
New Parkinson’s drug could slow or reverse progression of …
Aug 21, 2024 · “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is a long way to go for development of this treatment,” Michael S. Okun, M.D., Parkinson’s Foundation medical adviser and director at the Norman Fixel Institute for ...
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
Parkinson's disease - Latest research and news - Nature
3 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
Dec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
Mar 11, 2024 · Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
Brain study challenges long-held views about Parkinson's …
1 day ago · Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new ...